C-NRX

V:NRX - NurExone Biologic Inc. - https://www.nurexone.com

20:04:28 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
NRX - V	5.0	0.70	·	0.75	25.0	0.72			14.9	10	13	0.73 0.73 0.72	0.83 0.52	13:06:39	Jul 08	15 min RT 2¢
TSX-V - V	5.0	0.70	·	0.75	25.0	0.72			11.0	8	6	0.73 0.73 0.72	0.83 0.52	13:06:39		15 min
NEO ATS - U						0.73	+0.01	1.4	1.0	1	1	0.73 0.73 0.73		09:50:08		15 min
Pure - P						0.72			0.007		1			Mar 17		15 min
Chi-X - X						0.73	+0.01	1.4	2.0	1	1	0.73 0.73 0.73		09:50:08		15 min
CXD - D						0.72			0.1		1			Jun 23		15 min
TriAct - M						0.72			0.8	1	3					15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Show ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 13

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
13:23:38	M	0.72		150	80 National Bank	2 RBC	E
13:08:25	D	0.72		123	80 National Bank	7 TD Sec	E
13:06:39	M	0.72		350	2 RBC	33 Canaccord	E
13:06:39	V	0.72		2,000	84 ITG84	33 Canaccord	K
13:06:39	V	0.72		1,000	84 ITG84	33 Canaccord	K
12:03:40	P	0.75	0.03	7	19 Desjardins	7 TD Sec	E
09:50:08	U	0.73	0.01	1,000	13 Instinet	13 Instinet	K
09:50:08	X	0.73	0.01	2,000	13 Instinet	13 Instinet	K
09:50:08	V	0.73	0.01	2,000	13 Instinet	1 Anonymous	K
09:50:08	V	0.73	0.01	3,000	13 Instinet	13 Instinet	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2025-07-08 16:24	C:NRX	0.67	News Release200	New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model
2025-06-20 10:16	C:NRX	0.67	News Release200	Nurexone Biologic joins HealthTech Hub program
2025-06-04 19:38	C:NRX	0.71	News Release200	Nurexone presents at conference, to hold AGM June 18
2025-05-30 18:01	C:NRX	0.68	News Release200	Nurexone Biologic adviser to present at ASIA meeting
2025-05-27 08:59	C:NRX	0.66	News Release200	NurExone Biologic Inc. Announces First Quarter 2025 Financial Results and Provides Corporate Update
2025-05-27 08:42	C:NRX	0.66	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-05-27 08:42	C:NRX	0.66	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-05-09 03:27	C:NRX	0.66	News Release200	Nurexone's ExoPTEN data presented at annual meeting
2025-05-02 16:05	C:NRX	0.705	News Release200	NurExone Expands European Engagement with Investor Events in Germany and Switzerland
2025-04-24 16:55	C:NRX	0.64	Private Placement250	Nurexone Biologic 3,543,238-share private placement
2025-04-24 16:15	C:NRX	0.64	News Release200	NurExone to Showcase Breakthrough in Facial Nerve Regeneration at ISEV 2025
2025-04-22 20:18	C:NRX	0.65	News Release200	Nurexone appoints Licht as CEO of Exo-Top
2025-04-09 17:16	C:NRX	0.68	SEDAR MD & A815	SEDAR MD & A
2025-04-09 17:15	C:NRX	0.68	News Release200	NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update
2025-04-09 17:04	C:NRX	0.68	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2025-04-04 16:12	C:NRX	0.67	News Release200	Nurexone closes $2.3-million private placement
2025-03-14 16:42	C:NRX	0.65	News Release200	Nurexone completes preclinical study for ExoPTEN
2025-02-27 16:03	C:NRX	0.57	News Release200	NurExone Biologic to Present at MIXiii 2025; Professor Michael Belkin, Head of NurExone Ophthalmology Project, to Receive Lifetime Achievement Award
2025-02-14 16:03	C:NRX	0.61	News Release200	NurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation
2025-02-05 18:29	C:NRX	0.58	News Release200	Nurexone Biologic forms U.S.-based subsidiary

Date ET

Symbol

Price

Type

Headline

2025-07-08 16:24

C:NRX

0.67

News Release

New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model

2025-06-20 10:16

C:NRX